A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

NCT06919510 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Rectal Adenocarcinoma

Interventions

DRUG: lvonescimab
DRUG: CAPOX (oxaliplatin/capecitabine)
RADIATION: radiotherapy
PROCEDURE: Surgery or watch&wait

Sponsor

Sun Yat-sen University

Collaborators

[object Object]